["Medication, Administered": "Antithrombotic Therapy"]
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive antithrombotic therapy following stroke.
Inclusion Criteria: Includes only relevant concepts associated with single and multi-ingredient drugs. Oral, rectal, and injectable dose forms should be included. Antithrombotic medications includes only relevant concepts associated with anticoagulants and antiplatelet drugs.
Exclusion Criteria: Excludes codes for enoxaparin and heparin generally given for VTE prophylaxis.
Constrained to codes in the Medication, Administered: Antithrombotic Therapy value set (2.16.840.1.113883.3.117.1.7.1.201)
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing: The Relevant Period addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient),
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same)
NOTE – Measure developers should address multiple administrations over a period of time using CQL logic.